Non Hodgkin Lymphoma Clinical Trial

3′-Deoxy-3′-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Summary

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-[18F] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment.

PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.

View Full Description

Full Description

OBJECTIVES:

Primary

Evaluate the use of 3'-deoxy-3'-[18F] fluorothymidine (FLT) positron emission tomography (PET) imaging to measure tumor proliferation and the DNA synthetic pathway (thymidine kinase levels) in patients with cancer.

Secondary

Determine the efficacy of FLT PET imaging in detecting lesions and estimating response to treatment.

OUTLINE: Patients undergo up to four 3'-deoxy-3'-[18F] fluorothymidine positron emission tomography imaging procedures.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Meets one of the following criteria:

Histologically confirmed solid tumor or hematologic malignancy
Awaiting biopsy or surgery for cancer evaluation of a mass detected on exam or standard imaging

PATIENT CHARACTERISTICS:

Able to lie still in the PET scanner
Girth and weight must be suitable to enter the gantry
Not pregnant or nursing
Negative pregnancy test
Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

Not specified

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

80

Study ID:

NCT00935090

Recruitment Status:

Suspended

Sponsor:

Barbara Ann Karmanos Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Barbara Ann Karmanos Cancer Institute
Detroit Michigan, 48201, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

80

Study ID:

NCT00935090

Recruitment Status:

Suspended

Sponsor:


Barbara Ann Karmanos Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.